All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Tedopi,Undisclosed
Therapeutic Area: Oncology Product Name: OSE-2101
Highest Development Status: Undisclosed Product Type: Vaccine
Partner/Sponsor/Collaborator: European Investment Bank
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 15, 2021
Details:
This loan will help expand the clinical development of Tedopi® in combination with a checkpoint inhibitor in additional cancer indications.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
